The purpose of holding Insulet Corporation (PODD) stock is to participate in the company’s potential for long-term financial growth and to benefit from the increasing global adoption of advanced insulin management technology. Investors purchase PODD shares with the expectation that the company will successfully expand its market share, enhance its profitability through economies of scale, and maintain a leading technological edge in the diabetes device marketplace. For institutional investors, the stock serves as a key component of their healthcare and growth portfolios, providing exposure to a company that sits at the intersection of medical innovation and recurring-revenue consumer products. By holding the stock, investors effectively provide the corporation with the capital necessary to fund research and development, allowing it to compete effectively in the high-stakes global medical device industry and, hopefully, realize long-term capital appreciation as the enterprise grows.